Clinical Trial Update: A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing AZD1775 plus docetaxel versus placebo plus docetaxel in previously treated non-small cell lung cancer was terminated, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AZD1775 (Adavosertib)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Previously Treated Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-06-14